Aquire Wealth Advisors’s Zoetis ZTS Stock Holding History

Aquire Wealth Advisors’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-132	Closed	-$32K	–	266
2021 Q4	$32K	Buy	+132	New	+$28.9K	0.02%	104

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aquire Wealth Advisors's ZTS Position: Q1 2022 in Review

Aquire Wealth Advisors sold out of Zoetis (ZTS) in Q1 2022, closing a stake of 132 shares — an estimated $32K sold.

Aquire Wealth Advisors first reported a position in ZTS in Q4 2021 and held it in 1 quarter. The position peaked at $32K in Q4 2021. 1,637 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

Aquire Wealth Advisors reported no remaining Zoetis position as of Q1 2022 after selling out during the quarter.
Aquire Wealth Advisors sold 132 Zoetis shares in Q1 2022, an estimated $32K.
Aquire Wealth Advisors first reported a position in Zoetis in Q4 2021 and held it in 1 quarter.
Aquire Wealth Advisors's Zoetis position peaked at $32K in Q4 2021.
1,637 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Aquire Wealth Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.